Contract service agreement forMaster Services Agreement • July 3rd, 2024 • Delaware
Contract Type FiledJuly 3rd, 2024 JurisdictionThe Company has entered into a Master Services Agreement (“Supply Agreement”) with BioVectra Inc., (“BioVectra”). BioVectra will manufacture and supply cGMP-grade quantities of the Company’s PB2452 proprietary drug product (“Product”) for the Company’s potential PB2452 Phase 3 clinical trial as well as any work required to support the marketing authorization filing. A Commercial Supply Agreement is being put in place for the Product, if it is approved by the FDA.